Forthcoming articles in the July issue
A tale of two societies
Remembrances of factor VIII. Part 2
Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation
von Willebrand factor, endothelial dysfunction, and cardiovascular disease
Polymorphisms and platelet genotyping
Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms
Can anticoagulant treatment be tailored with biomarkers in patients with venous thromboembolism?
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism
Toward gene therapy for hemophilia A with novel adenoviral vectors
Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model
Parachutes and prophylaxis
Tailored prophylaxis in severe hemophilia A
Screening for children from families with Rendu–Osler–Weber disease
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants
Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis
Obesity and risk of venous thromboembolism among postmenopausal women
Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels
Plasminogen and plasmin activity in patients with coronary artery disease
Circulating endothelial microparticles in acute ischemic stroke
A genome-wide linkage scan for homocysteine levels suggests three regions of interest
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII
Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation1
The limits of simulation of the clotting system
International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain
Molecular evolution caught in action
Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation
Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene
von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectively
Critical role of ADP interaction with P2Y12 receptor in the maintenance of αIIbβ3 activation
Platelet septin complexes form rings and associate with the microtubular network
Human endothelial cells synthesize and release ADAMTS-13
Patterns of changes of anti-ADAMTS13 after plasma exchange
Activated partial thromboplastin time
Factor Xa protects cultured hippocampal neurons from glutamate toxicity
Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis
β-Thalassemia intermedia and pregnancy
Regulation of endogenous tissue-type plasminogen activator expression is modulated by the −7351C>T enhancer polymorphism
The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment
Extra-virgin vs. refined olive oil on postprandial hemostatic markers in healthy subjects
The impact of simvastatin on warfarin disposition and dose requirements
Can the PFA-100® be modified to detect P2Y12 inhibition?
More on
Platelet function analyzer (PFA-100)™ closure time in the evaluation of platelet disorders and platelet function
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function – a rebuttal
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function
Platelet function analyzer (PFA)-100®closure time in the evaluation of platelet disorders and platelet function
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs. Reply to a rebuttal
Talking about…
ANNOUNCEMENTS